StabiLux Biosciences, Inc. As a spin-out of Michigan Technological University, StabiLux has developed proprietary, high-brightness fluorophores (dyes) called NovoLux® High-Brightness Dyes ™. These innovative dyes enable biomedical researchers, particularly those using multi-color flow cytometry, to detect what was previously undetectable.

What sets StabiLux apart is their drop-in platform technology, which allows researchers to fully utilize their existing equipment without the need for additional parts or new software. By overcoming the limitations of current flow cytometry equipment, StabiLux’s high-brightness fluorophores offer a solution that accelerates time to market, improves data output, and enhances medical diagnostic discovery. Not only is StabiLux committed to advancing scientific research, but they also prioritize diversity and broader impacts.

They actively recruit talents from diverse backgrounds and contribute to societal and educational impacts in two major biomedical areas: flow cytometry for immunological use and drug discovery, and polymerase chain reaction (PCR) for virus detection, including combatting COVID-19 and future pandemics. With their groundbreaking technology and dedication to making a difference, StabiLux is leading the way towards a brighter future in biomedical research and diagnostics